CompoAtlas

ADVOCARE Joint ProMotion TM

Natural health product licensed in Canada

Licence holder
AdvoCare International, LLC
NPN or DIN-HM
80065953
Status
Active licence
Licence date
17 December 2015
Revision date
24 April 2017
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Chlorhydrate de 2-amino-2-désoxy-bêta-D-glucopyranose

Source : Exosquelette de crevette

500 mgNot calculated
Manganèse

Source : Sulfate de manganèse (II) monohydraté

1 mg3,000 µg
Centella asiatica

Source : Plante entière

Extract : Matériel brut sec

Extraction ratio : 8:1

Dry plant equivalent : 266.4 mg

33.3 mgNot calculated
Méthylsulfonylméthane

Source : Sulfone de diméthyl

33.3 mgNot calculated
Salix alba

Source : Écorce (tige)

Potency : 30 % Salicin

10 mgNot calculated

Non-medicinal ingredients

Gélatine, Stéarate de magnésium, Cellulose microcristalline, Dioxyde de silicium

PopulationAgeQuantity per servingFrequency
AdultesNot specified3 Capsule1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps the body to metabolize carbohydrates, fats and proteins. Helps in the development and maintenance of bones. Helps to maintain healthy cartilage. Helps to maintain joint health.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80065953

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Salix alba
    Read the warning, when it applies and the studies cited

    WILLOW BARK

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have asthma or peptic ulcer disease (EMA 2017).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners or products containing salicylates (e.g., acetylsalicylic acid or non-steroidal anti-inflammatory drugs) (EMA 2017).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Do not use if you are pregnant or breastfeeding (EMA 2017; Brinker 2010; Wichtl 2004; ESCOP 2003; Barnes et al. 2002; Blumenthal et al. 2000).

    6 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Do not use if you are allergic to salicylates (EMA 2017; Brinker 2010; Wichtl 2004, ESCOP 2003; Barnes et al. 2002; Blumenthal et al. 2000).

    6 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    When using this product you may experience gastrointestinal discomfort/disturbances (EMA 2017; Brinker 2010; Wichtl 2004; ESCOP 2003; Barnes et al. 2002; Blumenthal et al. 2000)

    6 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 28 March 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

Photograph the packaging

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

List recorded in 2017. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line